Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Bone marrow culture for cancer Institute of Human Genetics Foundation for Research in Genetics and Endocrinology India | 4 | 24 |
|
Institute of Human Genetics Foundation for Research in Genetics and Endocrinology India | 1 | 2 |
|
Centogene AG - the Rare Disease Company Germany | 218 | 135 |
|
ABL1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 740 | 728 |
|
Invitae Connective Tissue Disorders Panel Invitae United States | 195 | 92 |
|
Sentara Healthcare Laboratory Services United States | 1 | 2 |
|
Hematological Malignancy Fusion Panel Laboratory for Molecular Pediatric Pathology Boston Children's Hospital United States | 8 | 71 |
|
BCR/ABL IS Quant CML and JAK2 V617F Quant and JAK2 Exon 12-15 PathGroup United States | 7 | 3 |
|
BCR/ABL IS Quant CML and JAK2 V617F Quant PathGroup United States | 7 | 3 |
|
BCR CML IS_expanded JAK2 +V617F quant_CALR_MPL PathGroup United States | 11 | 5 |
|
PathGroup United States | 11 | 5 |
|
BCR/ABL CML IS, CALR and JAK2 exon 12-15 (V617F Quant) PathGroup United States | 10 | 4 |
|
Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR + BCR/ABL1 IS PathGroup United States | 17 | 160 |
|
BCR/ABL IS Quant CML+CALR+Expanded JAK2 PathGroup United States | 10 | 4 |
|
PathGroup United States | 11 | 5 |
|
BCR/ABL Quant Non-CML and JAK2 V617F Mutation Detect and Quant PathGroup United States | 7 | 3 |
|
BCR/ABL, CALR, expanded JAK2, MPL PathGroup United States | 11 | 5 |
|
Comprehensive HemeComplete Profile + CALR PCR + FLT3 PCR + BCR/ABL1 PathGroup United States | 17 | 160 |
|
BCR/ABL Quant Non-CML, CALR and JAK2 exon 12-15 (V617F Quant) PathGroup United States | 10 | 4 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.